MARKETS
Cryptocurrency

DataMeds AI, Datavault AI Amend Definitive Agreement To Expand PharmacyChain Blockchain-Related Technology Licensing Relationship Beyond Pharmaceutical Distribution

Jul 29, 2026 · 10:17 AM ET· updated 3h ago

DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMEDS"), a Health IT company leveraging its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contacts platform PharmacyChain™ to provide integrated

Share
Why It Matters

DataMeds AI and Datavault AI made their business deal bigger—they'll now use blockchain technology in more ways beyond just drug delivery. When companies expand partnerships, it can show they believe in their technology and have room to grow.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.